Green Scientific Labs Holdings Inc.
GSL
CNSX
| 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -62.12% | -150.37% | -41.61% | -44.49% | -54.62% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -62.12% | -150.37% | -41.61% | -44.49% | -54.62% |
| Cost of Revenue | -52.78% | -122.16% | -12.71% | -56.65% | -37.47% |
| Gross Profit | -70.56% | -155.48% | -55.73% | -38.31% | -63.61% |
| SG&A Expenses | -59.12% | -93.75% | -20.00% | 11.03% | 33.34% |
| Depreciation & Amortization | -56.24% | -341.27% | 120.01% | 38.90% | 19.61% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -57.46% | -106.73% | -4.63% | -4.67% | 7.21% |
| Operating Income | 53.99% | 48.43% | -53.66% | -192.63% | -7,476.80% |
| Income Before Tax | 47.24% | 61.24% | -64.64% | -179.96% | -858.74% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 47.24% | 61.24% | -64.64% | -179.96% | -858.74% |
| Earnings from Discontinued Operations | 80.36% | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 57.88% | 33.90% | -64.64% | -179.96% | -1,312.89% |
| EBIT | 53.99% | 48.43% | -53.66% | -192.63% | -7,476.80% |
| EBITDA | 53.14% | 91.88% | -65.17% | -769.43% | -582.54% |
| EPS Basic | 59.61% | 52.04% | -90.73% | -225.75% | -868.84% |
| Normalized Basic EPS | 54.24% | 84.66% | -93.58% | -225.67% | -632.93% |
| EPS Diluted | 56.54% | 52.50% | -93.64% | -233.33% | -868.84% |
| Normalized Diluted EPS | 54.24% | 84.66% | -93.58% | -225.67% | -632.93% |
| Average Basic Shares Outstanding | 4.22% | 30.52% | -13.70% | -13.97% | 46.21% |
| Average Diluted Shares Outstanding | 4.22% | 30.52% | -13.70% | -13.97% | 46.21% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |